Immunovant Inc

IMVTNASDAQ · USD
37.65USD0.00 (+3.50%)
1210

Immunovant Inc (IMVT) Option Chain

As of September 17, 2026, Immunovant Inc is trading at $37.65, a +3.50% change from the previous close. The nearest expiration is Sep 18, 2026. Implied volatility is 63.1%. IV Rank is 17%.

Read more

Tracking the IMVT option chain helps you see every strike and expiry on Immunovant Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Immunovant Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of IMVT options activity at a glance. Use our scanner to monitor the IMVT option chain in real time and filter for the IMVT options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For IMVT stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the IMVT option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where IMVT stock options are being actively traded and where they are not.

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Immunovant Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen IMVT options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of IMVT stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile58.33% Neutral
  • Market cap (M$)7,777
  • 52 weeks high-17.11%
  • 52 weeks low158.23%
  • Analyst recommendationStrong Buy
    1.47
  • Target price$48.88
    29.83% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-09
  • P/E
  • Future P/E
  • EPS (ttm)-2.81
  • EPS growth next 5 years12.21%

As of September 17, 2026

2026-09-18
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
43.03101.651.653.3036.00-1.042.600.002.600156.97
63.393301.050.651.7037.00+1.700.502.500.001.5001236.61
80.1310101.700.001.7038.00+4.450.553.500.351.6772119.87
90.9427200.750.000.7539.00+7.201.354.101.351.370199.06
96.539200.950.000.9540.00+9.952.255.002.351.270443.47

As of September 17, 2026

Scan the full option chain in one place

Browse the full IMVT option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial